Literature DB >> 12604271

Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test.

Yoram Barak1, Mor Lavie, Anat Achiron.   

Abstract

The clock drawing test (CDT) is a complex task assessing integrative functions, abstract thinking and visuospatial organization. In the present study we evaluated the CDT as a possible screening instrument for early cognitive impairment in multiple sclerosis (MS) patients. In total, 107 MS patients completed the CDT as well as a battery assessing five cognitive domains. There were 73 female and 34 male participants (mean age 45.4+/-11.6 years, range 19-69). The majority (76/107) were diagnosed with a relapsing-remitting disease course. Mean expanded disability status scale (EDSS) score was 4.3+/-2.4 (range 0-8). The CDT was scored on a 1-6 point scale with "1" being a perfect score and "6" reflecting severe disorganization. Mean CDT score was 2.6+/-1.4. In 53% of patients the CDT was normal while in 11.2% dementia was apparent. The CDT score did not correlate with the total EDSS. Significant correlations were obtained with the mental functional system score of the EDSS (r = 0.78; p = 0.0001), visual learning and recall, sustained attention and concentration. Our findings demonstrate the sensitivity of the CDT to several cognitive domains. The absence of correlation with total EDSS score coupled with significant correlation with the mental functional system suggests that the CDT may be useful for screening MS patients. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12604271     DOI: 10.1054/jocn.2002.1110

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis.

Authors:  Sanela Slavković; Milica Lazić; Cynthia Honan; Čongor Nađ; Nina Brkić-Jovanović; Špela Golubović
Journal:  Med Princ Pract       Date:  2019-03-04       Impact factor: 1.927

2.  Utility of the INECO frontal screening (IFS) in the detection of executive dysfunction in patients with relapsing-remitting multiple sclerosis (RRMS).

Authors:  D Bruno; T Torralva; V Marenco; J Torres Ardilla; S Baez; E Gleichgerrcht; V Sinay; M Roca
Journal:  Neurol Sci       Date:  2015-06-26       Impact factor: 3.307

Review 3.  Quality of life in multiple sclerosis.

Authors:  Józef A Opara; Krystyna Jaracz; Waldemar Brola
Journal:  J Med Life       Date:  2010 Oct-Dec

4.  Assessment of early cognitive impairment in patients with clinically isolated syndromes and multiple sclerosis.

Authors:  Leyla Baysal Kıraç; Özgül Ekmekçi; Nur Yüceyar; Ayşe Sağduyu Kocaman
Journal:  Behav Neurol       Date:  2014-04-14       Impact factor: 3.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.